Insider: Ciaffoni Joseph President and CEO - COLLEGIUM PHARMACEUTICAL, INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 275,000 | 0 | 275,000 |
| Value | $9,460,000.00 | $0.00 | $9,460,000.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 12/21/2023 | DDS | 4,357 | Direct | COM | $30.38 | $132,376.55 | 275,000 |
| 12/20/2023 | DDS | 26,454 | Direct | COM | $30.40 | $804,209.54 | 275,000 |
| 12/19/2023 | DDS | 14,516 | Direct | COM | $30.03 | $435,941.61 | 275,000 |
| 12/18/2023 | DDS | 27,798 | Direct | COM | $30.04 | $834,935.17 | 275,000 |
| 06/02/2023 | DDS | 30,272 | Direct | COM | $21.58 | $653,172.89 | 276,000 |
| 06/02/2023 | DDS | 1,000 | Direct | COM | $22.25 | $22,251.10 | 275,000 |
| 06/01/2023 | DDS | 31,272 | Direct | COM | $22.09 | $690,757.83 | 306,272 |
| 05/31/2023 | DDS | 31,272 | Direct | COM | $21.87 | $683,796.68 | 337,544 |
| 05/30/2023 | DDS | 31,271 | Direct | COM | $21.90 | $684,906.82 | 368,816 |
| 02/13/2023 | DDS | 11,250 | Direct | COM | $26.88 | $302,400.00 | 400,087 |
| 12/27/2022 | DDS | 400 | Direct | COM | $24.19 | $9,676.00 | 248,750 |
| 12/27/2022 | DDS | 1,804 | Direct | COM | $23.65 | $42,664.60 | 249,150 |
| 12/23/2022 | DDS | 147 | Direct | COM | $23.00 | $3,381.00 | 250,954 |
| 12/22/2022 | DDS | 110 | Direct | COM | $23.00 | $2,530.00 | 251,101 |
| 12/21/2022 | DDS | 7,333 | Direct | COM | $23.11 | $169,465.63 | 251,211 |
| 12/20/2022 | DDS | 9,375 | Direct | COM | $23.07 | $216,281.25 | 258,544 |
| 12/19/2022 | DDS | 1,134 | Direct | COM | $23.01 | $26,093.34 | 267,919 |
| 12/02/2022 | DDS | 54,400 | Direct | COM | $23.07 | $1,255,008.00 | 269,053 |
| 12/01/2022 | DDS | 76,653 | Direct | COM | $22.47 | $1,722,392.91 | 323,453 |
| 11/28/2022 | DDS | 43 | Direct | COM | $22.00 | $946.00 | 323,453 |
| 11/18/2022 | DDS | 1,989 | Direct | COM | $22.02 | $43,797.78 | 323,453 |
| 03/01/2022 | DDS | 65,083 | Direct | COM | $18.37 | $1,195,574.71 | 335,858 |
| 03/01/2022 | DDS | 11,011 | Direct | COM | $19.04 | $209,649.44 | 324,847 |
| 06/02/2021 | DDS | 5,861 | Direct | COM | $22.81 | $133,689.41 | 267,774 |
| 06/01/2021 | DDS | 10,829 | Direct | COM | $23.33 | $252,640.57 | 273,635 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research